Cav1.3-C-terminus Restores Electrical and Contractile Functions in hiPSC-derived Cardiomyocytes Model of Heart Failure
Yvonne Sleiman, Jean‐Baptiste Reisqs, Mohamed Boutjdir
This study uses Cav1.3-C-terminus gene therapy to restore electrophysiological and contractile functions in hiPSC-derived cardiomyocytes with ET-1-induced heart failure.
bioRxiv · Oct 28, 2026 · PreprintCell Biology